Patients are hearing that Spiriva (tiotropium) might increase the risk of stroke
Patients are hearing that Spiriva (tiotropium) might increase the risk of stroke.
A recent analysis shows a slightly higher risk of stroke in patients using Spiriva...about 2 additional cases per 1000 patients per year.
This is a surprise. So far there's been no reason to suspect a link between inhaled anticholinergics and stroke.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote